Search

everythinglearnresearchcommunity

for

Search:↓

Papulopustular rosacea is an inflammatory skin condition treatable with lifestyle changes and medications.

Substance from human umbilical cord blood cells promotes hair growth.

Prolactin affects hair growth and skin conditions, and could be a target for new skin disease treatments.

Clascoterone may be a promising treatment for hair loss.

Storing hair follicles in a special buffer with certain inhibitors can increase hair growth and improve transplant results.

Tofacitinib, a medication for arthritis, showed potential for treating severe hair loss in a small Brazilian case series, but more research is needed.

A protein called ectodysplasin-A2 increases a hair growth inhibitor in balding cells, which could be a target for hair loss treatment.

PDE inhibitors, especially PDE4 inhibitors like apremilast, are effective for certain inflammatory skin conditions but have side effects and can be costly.

Janus kinase inhibitors show promise in treating alopecia areata but need more safety research.

Lyophilized platelet-rich plasma is beneficial and effective for various medical treatments, including tissue regeneration and hair regrowth.

Keratin hydrogel from human hair helps rats recover better from spinal cord injuries.

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

Cyclosporine A was found to increase hair growth in mouse whisker follicles.

COVID-19 can cause temporary hair loss, which is commonly reversible with treatment.

A device was made in 2008 to measure hair loss severity. Other findings include: frizzy mutation in mice isn't related to Fgfr2, C/EBPx marks preadipocytes, Cyclosporin A speeds up hair growth in mice, blocking plasmin and metalloproteinases hinders healing, hyperbaric oxygen helps ischemic wound healing, amniotic membranes heal wounds better than polyurethane foam, rhVEGF165 from a fibrin matrix improves tissue flap viability and induces VEGF-R2 expression, and bFGF enhances wound healing and reduces scarring in rabbits.

Short-chain fatty acids from *Cutibacterium acnes* cause skin inflammation, contributing to acne.

The p53 protein has complex, sometimes contradictory functions, including tumor suppression and promoting cell survival.

Insulin resistance increases the risk of developing type 2 diabetes and other health issues.

SHBG may be a useful early indicator and treatment target for PCOS.

Early signs of PCOS in girls, like irregular periods and polycystic ovaries, suggest a need for early diagnosis and intervention to prevent further health issues.

Chemokine signaling is important for hair development.

Oxidative stress plays a significant role in alopecia areata, and new treatments may include JAK inhibitors and antioxidants.

Immune cells affect hair growth and could lead to new hair loss treatments.

The document concludes that Cutaneous Lupus Erythematosus has different forms, is influenced by genetic and environmental factors, and can be treated with various medications, but more targeted therapies are needed.

Storing hair follicles in special buffers with added protective substances can increase hair growth and reduce cell death.

The document concludes that there have been significant improvements in diagnosing and treating skin diseases, including melanoma, with new techniques and therapies.

Blocking BMP signaling causes hair loss and disrupts hair growth cycles.

The TGF-β family helps control how cells change and move, affecting skin, hair, and organ development.

New targeted therapies for hair loss from alopecia areata show promise, with personalized treatment expected in the future.

Ovol2 is crucial for hair growth and skin healing by controlling cell movement and growth.